Context Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-72,334
Closed -$528K 428
2022
Q4
$528K Hold
72,334
0.04% 216
2022
Q3
$501K Hold
72,334
0.03% 321
2022
Q2
$506K Hold
72,334
0.04% 341
2022
Q1
$598K Hold
72,334
0.04% 371
2021
Q4
$781K Hold
72,334
0.06% 320
2021
Q3
$871K Sell
72,334
-5,162
-7% -$58.3K 0.09% 242
2021
Q2
$940K Hold
77,496
0.09% 244
2021
Q1
$1.08M Buy
77,496
+8,059
+12% +$113K 0.11% 202
2020
Q4
$983K Hold
69,437
0.13% 140
2020
Q3
$858K Buy
+69,437
New +$804K 0.19% 94

Other funds holding AMYT

Context Capital Management's AMYT Position: Q1 2023 in Review

Context Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 72,334 shares — an estimated $528K sold.

Context Capital Management first reported a position in AMYT in Q3 2020 and held it in 10 quarters. The position peaked at $1.08M in Q1 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Context Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Context Capital Management sold 72,334 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $528K.
  • Context Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
  • Context Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $1.08M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.